GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target ...

We combine progressive healthcare education and patient care with world-class research and outstanding teaching facilities in order to help you to become the very best doctor you can be. But don't ...

Jefferies analyst reiterated a Buy rating for Globus Medical (NYSE:GMED), with a steady price target of $105.00, following the company's announcement of its plans to acquire Nevro Corp . (NYSE:NVRO), ...

Request To Download Free Sample of This Strategic Report @ Driving Forces Behind Growth: The exponential growth of the North America medical implant market is propelled by several key drivers.

Request To Download Free Sample of This Strategic Report @ Driving Forces of Growth: The unprecedented growth of the medical implant market is propelled by several key factors. Firstly, the aging ...

The spinal surgical robots market is experiencing rapid growth as healthcare facilities worldwide adopt robotic-assisted technologies for spine surgeries. These robots enhance precision, reduce ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Audubon, PA-based Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its ...